Dermatological lesion in tattoo area
DOI:
https://doi.org/10.51481/amc.v64i2.1228Keywords:
Carcinoma, Squamous Cell, Keratoacanthoma, tattooingAbstract
Tattoos represent a unique in vivo situation where many metallic salts and organic dyes remain on the skin for a lifetime. As a result of a greater number of tattoos performed, the incidence of skin complications associated with tattoos has increased. In addition, in the last 30 years, there has been an increment in reports of skin tumors within tattoos; however, many authors continue to consider it is a coincidental event. The possible local carcinogenic effects of tattoos remain unclear. It is believed that this effect could be multifactorial, combining needle trauma, chronic local inflammation, external factors such as an ultraviolet rays (UV) exposure and a possible pro-cancer effect of the inks. Large-scale epidemiological and clinical studies are needed to demonstrate this association. A case of a known healthy 40-year-old male is presented, in whom 2 months after a tattoo was performed on his right shoulder, he developed a lesion with clinical characteristics of a keratoacanthoma in which the histological diagnosis of a well differentiated and invasive squamous cell carcinoma was made.
Downloads
References
Junqueira AL, Wanat KA, Farah RS. Squamous neoplasms arising within tattoos: clinical presentation, histopathology and management. Clin Exp Dermatol. 2017;42:601-6. DOI:10.1111/ced.13183
Kluger N, Seité S, Taieb C. The prevalence of tattooing and motivations in five major countries over the world. J Eur Acad Dermatol and Venereol. 2019;33:484-486. DOI:10.1111/jdv.15808
Kazandjieva J, Tsankov N. Tattoos: Dermatological complications. Clin Dermatol. 2007;25:375-82. DOI:10.1016/j.clindermatol.2007.05.012
Islam PS, Chang C, Selmi C, Generali E, Huntley A, Teuber SS, et al. Medical Complications of Tattoos: A Comprehensive Review. Clin Rev Allergy Immunol. 2016;50:273-86. DOI:10.1007/s12016-016-8532-0
Serup J. How to diagnose and classify tattoo complications in the clinic: a system of distinctive patterns. Curr Probl Dermatol. 2017;52:58-73. DOI: 10.1159/000450780
van der Bent SA, Rauwerdink D, Oyen EM, Maijer KI, Rustemeyer T, Wolkerstorfer A. Complications of tattoos and permanent makeup: overview and analysis of 308 cases. J of Cosmet Dermatol. 2021;20:3630-3641. DOI:10.1111/jocd.14498
Gualdi G, Fabiano A, Moro R, Venturuzzo A, Monari P, Calzavara-Pinton P, et al. Tattoo: Ancient art and current problems. J Cosmet Dermatol. 2021;20:602-604. DOI:10.1111/jocd.13548
Leijs M, Schaefer H, Rübben A, Cacchi C, Rustemeyer T, van der Bent S. Cutaneous malignancies in tattoos, a case series of six patients. Curr Oncol. 2021;28:4721-4737. DOI: 10.3390/curroncol28060398.
Kluger N. Skin tumors arising in tattoos: coincidental or upcoming public health issue? Expert. Rev Dermatol. 2009;4:313-135. DOI:10.1586/edm.09.28
Kluger N, Koljonen V. Tatoos, inks, and cancer. Lancet Onol. 2012;13:161.168 DOI:10.1016/s1470-2045(11)70340-0
Nicolas JF, Thivolet J. EJD 20th Anniversary. Eur. J. Dermatol. 2011;21:3-4 DOI:10.1684/ejd.2011.1211
Cherkaoui El Baraka F, Kluger N, Ollivier I, Bourgoin R, Grossin M, et al. Melanoma dentro de los tatuajes: dos casos y una revisión sistémica de la literatura. Ann Dermatol Venereol. 2020 147:285-292. DOI:10.1016/j.annder.2019.10.024
Cohen PR, Erickson CP, Uebelhoer NS, Calame A. Tattoo associated basal cell carcinoma: coincidente o coincidence. Biomed. Hub. 2020; 5:508208. DOI:10.1159/000508208
Sarma DP, Dentlinger RB, Forystek AM, Stevens T, Huerter C. Poorly differentiated squamous cell carcinoma arising in tattooed skin. Case Rep Med. 2010;2010:1-3. DOI:10.1155/2010/431813
Pitarch G, Martínez-Menchón T, Martínez-Aparicio A, Sánchez-Carazo JL, Muñoz D, Fortea JM. Squamous cell carcinoma over tattoos. J Am Acad Dermatol. 2007;56:1072-1073. DOI:10.1016/j.jaad.2007.02.032
Gon AS, Minelli L, Meissner M. Keratoacanthoma in a tattoo. Dermatol Online J. 2009;15:7. DOI:10.5070/d3708608rr
Goldenberg G, Patel S, Patel MJ, Williford P, Sangueza O. Eruptive squamous cell carcinomas, keratoacanthoma type, arising in a multicolor tattoo. J Cutan Pathol. 2007;35:62-64. DOI:10.1111/j.1600-0560.2007. 00764.x
Ortiz A, Yamauchi PS. Rapidly growing squamous cell carcinoma from permanent makeup tattoo. J Am Acad Dermatol. 2009;60:1073-1074. DOI:10.1016/j.jaad.2008.11.902
Kluger N, Plantier F. Pseudo-epitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma occurring within tattoos: diagnostic issues. J Am Acad Dermatol. 2007;57:901-902. DOI:10.1016/j.jaad.2007.06.021
Kluger N, Cribier B. Keratoacanthomas and squamous cell carcinomas on tattoos: a review of 42 cases. Dermatology. 2021;237:309-312. DOI:10.1159/000509728
Sangueza OP, Yadav S, White CR, Braziel RM. Evolution of B-cell lymplhoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. Am J Dermatopathol. 1992;14:408-413. DOI:10.1097/00000372-199210000-00006
Baker PA, O'Dowd GJ, Khan IU. Dermatofibrosarcoma protuberans arising in a decorative tattoo. Sarcoma. 2005;9:37-41 DOI:10.1080/13577140500094289
West CC, Morritt AN, Pedelty L, Lam DG. Cutaneous leiomyosarcoma arising in a tattoo - ""a tumour with no humour"". J Plast Reconstr Aesthet Surg. 2009;62:79-80 DOI:10.1016/j.bjps.2008.09.021
Balfour E, Olhoffer I, Leffell D, Handerson T. Massive pseudoepitheliomatous hyperplasia: an unusual reaction to a tattoo. Am J Dermatopathol 2003;25:338-340. DOI:10.1097/00000372-200308000-00010
Swigost AJ, Peltola J, Jacobson-Dunlop E, Goldfarb N. Tattoo-related squamous proliferations: a spectrum of reactive hyperplasia. Clin Exp Dermatol. 2018;43:728-732. DOI:10.1111/ced.13559
Takai T. Advances in histopathological diagnosis of keratoacanthoma. J Dermatol. 2017;44:304-314. DOI:10.1111/1346-8138.13696
Weedon DD, Malo J, Brooks D, Williamson R. Squamous cell carcinoma arising in keratoacanthoma: a neglected phenomenon in the elderly. Am J Dermatopathol. 2010;32:423-426. DOI:10.1097/dad.0b013e3181c4340a
Sanchez YE, Simón P, Requena L, Ambrojo P, de Eusebio E. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant. Am J Dermatopathol. 2000;22:305-310. DOI:10.1097/00000372-200008000-00002
Kwiek B, Schwartz RA. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol. 2016;74:1220-1233. DOI:10.1016/j.jaad.2015.11.033
Piccolo V, Baroni A, Russo T, Schwartz RA. Ruocco's immunocompromised cutaneous district. Int J Dermatol. 2015;55:135-141. DOI:10.1111/ijd.13086
Wolf R, Wolf D, Ruocco V, Ruocco E. Wolf's isotopic response: The first attempt to introduce the concept of vulnerable areas in dermatology. Clin Dermatol. 2014;32:557-560. DOI:10.1016/j.clindermatol.2014.04.002
Caccavale S, Kannangara A, Ruocco E. The immunocompromised cutaneous district and the necessity of a new classification of its disparate causes. Indian J. Dermatol Venereol Leprol. 2016;82:227. DOI:10.4103/0378-6323.174422
Ruocco V, Ruocco E, Piccolo V, Brunetti G, Guerrera LP, Wolf R. The immunocompromised district in dermatology: A unifying pathogenic view of the regional immune dysregulation. Clin Dermatol.2014;32:569-576. DOI:10.1016/j.clindermatol.2014.04.004
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
